AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8160597 — intervention group
Group type: COMPARATOR
Intervention: Antiarrhythmic drugs (amiodarone or sotalol)
Number of subjects: 1000
Study 29784559 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodic stimulation
Number of subjects: 0
Study 29784559 — intervention group
Group type: COMPARATOR
Intervention: Cathodic stimulation
Number of subjects: 0
Study 27601500 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling exercise
Number of subjects: 31
Study 27601500 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 31
Study 27601500 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling and resistance exercise
Number of subjects: 31
Study 27601500 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 31
Study 23870670 — intervention group
Group type: EXPERIMENTAL
Intervention: Ragweed MATA MPL (short ragweed pollen allergoid adsorbed to L‐Tyrosine + MPL)
Number of subjects: 228
Study 23870670 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 228
Study 22784406 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-based learning intervention
Number of subjects: 28
Study 22784406 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical reading intervention
Number of subjects: 28
Study 22784406 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study 20828584 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing counseling sessions
Number of subjects: 452
Study 19017582 — intervention group
Group type: EXPERIMENTAL
Intervention: Quit Smoking Network (QSN) intervention condition
Number of subjects: 0
Study 19017582 — intervention group
Group type: COMPARATOR
Intervention: Active Lives control condition
Number of subjects: 0
Study 16736336 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted Nissen fundoplication
Number of subjects: 20
Study 16736336 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Nissen fundoplication
Number of subjects: 20
Study 12763714 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed stage-targeted print intervention (single mailing of a letter and full-color booklets)
Number of subjects: 462
Study 12763714 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 462
Study 10793597 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (10 puffs via metered dose inhaler)
Number of subjects: 16
Study 10793597 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium (10 puffs via metered dose inhaler)
Number of subjects: 16
Study 8762211 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine gastrointestinal therapeutic system (30 mg/day)
Number of subjects: 58
Study 8762211 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine retard (20 mg twice a day)
Number of subjects: 58
Study 8762211 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 1560686 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen (FRI, n = 30)
Number of subjects: 84
Study 1560686 — intervention group
Group type: COMPARATOR
Intervention: N-hyoscine butylbromide (HBB, n = 25)
Number of subjects: 84
Study 1560686 — intervention group
Group type: COMPARATOR
Intervention: Pentazocine (PTZ, n = 29)
Number of subjects: 84
Study 4008907 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic radionuclide imaging (GE scintigraphy) after acid loading and maneuvers (Valsalva, abdominal compression)
Number of subjects: 30
Study 4008907 — intervention group
Group type: EXPERIMENTAL
Intervention: Redefined abnormal reflux index greater than 1.7%
Number of subjects: 30
Study 4008907 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 30
Study 30497799 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived usefulness of information for mood self-management at T1
Number of subjects: 120
Study 30497799 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of depressive symptoms at T0
Number of subjects: 120
Study 30497799 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health-related quality of life at T0
Number of subjects: 120
Study 29517671 — intervention group
Group type: EXPERIMENTAL
Intervention: McGrath videolaryngoscope (ML group)
Number of subjects: 44
Study 29517671 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope (DL group)
Number of subjects: 44
Study 27084733 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (IH) combined with body weight‐supported treadmill training (BWSTT)
Number of subjects: 0
Study 27084733 — intervention group
Group type: COMPARATOR
Intervention: Normoxia (Nx) combined with body weight‐supported treadmill training (BWSTT)
Number of subjects: 0
Study 24432350 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of an intimate other
Number of subjects: 126
Study 24432350 — intervention group
Group type: COMPARATOR
Intervention: Presence of an experimenter
Number of subjects: 126
Study 24432350 — intervention group
Group type: COMPARATOR
Intervention: Alone, aware of video recording
Number of subjects: 126
Study 21822745 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonated thin liquids (CTL)
Number of subjects: 17
Study 21822745 — intervention group
Group type: COMPARATOR
Intervention: Noncarbonated thin liquids (NCTL)
Number of subjects: 17
Study 21175024 — intervention group
Group type: EXPERIMENTAL
Intervention: Bandtite glass ionomer cement
Number of subjects: 75
Study 21175024 — intervention group
Group type: EXPERIMENTAL
Intervention: Granitec glass ionomer cement
Number of subjects: 75
Study 21175024 — intervention group
Group type: EXPERIMENTAL
Intervention: Ariadent glass ionomer cement
Number of subjects: 75
Study 17085459 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid
Number of subjects: 263
Study 17085459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study 16135638 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 21
Study 16135638 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 11907490 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (rhGH)
Number of subjects: 30
Study 11907490 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 9444341 — intervention group
Group type: EXPERIMENTAL
Intervention: 24‐ga IV needle size
Number of subjects: 38
Study 9444341 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged tourniquet time
Number of subjects: 38
Study 9444341 — intervention group
Group type: EXPERIMENTAL
Intervention: Underfilling of Vacutainer tubes
Number of subjects: 38
Study 7617471 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (NCR) at doses of 1.0 mg, 1/4 mg, 1/16 mg, or 1/64 mg
Number of subjects: 30
Study 7617471 — intervention group
Group type: COMPARATOR
Intervention: Control portography without NCR
Number of subjects: 30
Study 2239717 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (400 mg twice a day)
Number of subjects: 9
Study 2239717 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg twice a day)
Number of subjects: 9
Study 2239717 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (theophylline and atenolol)
Number of subjects: 9
Study 2239717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 684774 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 0
Study 684774 — intervention group
Group type: COMPARATOR
Intervention: Hormonal therapy
Number of subjects: 0
Study 684774 — intervention group
Group type: COMPARATOR
Intervention: Hormonal therapy combined with external irradiation
Number of subjects: 0
Study 31074576 — intervention group
Group type: EXPERIMENTAL
Intervention: BOOST‐TLC program (motivational telephone calls for 24 months)
Number of subjects: 104
Study 31074576 — intervention group
Group type: COMPARATOR
Intervention: Control group (monthly automated phone message reminders)
Number of subjects: 104
Study 30392473 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g refined cold-pressed flaxseed oil providing 4.7 g ALA (n 29)
Number of subjects: 59
Study 30392473 — intervention group
Group type: COMPARATOR
Intervention: 10 g high-oleic sunflower oil as control (n 30)
Number of subjects: 59
Study 28913833 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjoint family‐based treatment (FBT)
Number of subjects: 107
Study 28913833 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent‐focused treatment (PFT)
Number of subjects: 107
Study 26531186 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiotocography augmented by fetal scalp blood lactate analysis
Number of subjects: 600
Study 26531186 — intervention group
Group type: COMPARATOR
Intervention: Cardiotocography alone
Number of subjects: 600
Study 24018697 — intervention group
Group type: EXPERIMENTAL
Intervention: Grammatically complete prompts
Number of subjects: 5
Study 24018697 — intervention group
Group type: COMPARATOR
Intervention: Telegraphic prompts
Number of subjects: 5
Study 21549069 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐18 levels in sepsis group
Number of subjects: 38
Study 21549069 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐10 levels in sepsis group
Number of subjects: 38
Study 21549069 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐18 levels in death group vs survival group
Number of subjects: 38
Study 21549069 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐10 levels in death group vs survival group
Number of subjects: 38
Study 21549069 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐18/IL‐10 ratio in non-survivors vs survivors
Number of subjects: 38
Study 19203564 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% meloxicam solution (1 drop t.i.d. for 30 days)
Number of subjects: 0
Study 19203564 — intervention group
Group type: COMPARATOR
Intervention: 0.1% diclofenac solution (1 drop t.i.d. for 30 days)
Number of subjects: 0
Study 17577461 — intervention group
Group type: EXPERIMENTAL
Intervention: CS-706 10 mg
Number of subjects: 150
Study 17577461 — intervention group
Group type: EXPERIMENTAL
Intervention: CS-706 50 mg
Number of subjects: 150
Study 17577461 — intervention group
Group type: EXPERIMENTAL
Intervention: CS-706 100 mg
Number of subjects: 150
Study 17577461 — intervention group
Group type: EXPERIMENTAL
Intervention: CS-706 200 mg
Number of subjects: 150
Study 17577461 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib 400 mg
Number of subjects: 150
Study 17577461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 15204271 — intervention group
Group type: EXPERIMENTAL
Intervention: Effort perception at the shoulder
Number of subjects: 31
Study 15204271 — intervention group
Group type: EXPERIMENTAL
Intervention: Effort perception at the torso
Number of subjects: 31
Study 12561647 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergenic extract pollen Cynodon dactylon (L) Pers skin prick test
Number of subjects: 200
Study 12561647 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group (no intervention)
Number of subjects: 200
Study 9660536 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent schedule (IS), oral administration of UFT (130 mg/m2/b.i.d.) with 2 days rest a week
Number of subjects: 10
Study 9660536 — intervention group
Group type: COMPARATOR
Intervention: Continuous schedule (CS), consecutive administration of UFT (130 mg/m2/b.i.d.)
Number of subjects: 10
Study 8122955 — intervention group
Group type: EXPERIMENTAL
Intervention: Relapse prevention plus desipramine hydrochloride
Number of subjects: 139
Study 8122955 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical management plus desipramine
Number of subjects: 139
Study 8122955 — intervention group
Group type: COMPARATOR
Intervention: Relapse prevention plus placebo
Number of subjects: 139
Study 8122955 — intervention group
Group type: COMPARATOR
Intervention: Clinical management plus placebo
Number of subjects: 139
Study 8122955 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 139
Study 8122955 — intervention group
Group type: EXPERIMENTAL
Intervention: Relapse prevention
Number of subjects: 139
Study 8122955 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical management
Number of subjects: 139
Study 8122955 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed subjects
Number of subjects: 139
Study 2501967 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous infusion of GHRH (1-29)NH2 at doses of 5 and 10 micrograms/kg/hour
Number of subjects: 5
Study 2501967 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pyridostigmine 60 mg
Number of subjects: 5
Study 367457 — intervention group
Group type: EXPERIMENTAL
Intervention: Agar (1 g/kg/day) orally in 4 daily doses from the 1st to the 5th day of life
Number of subjects: 40
Study 367457 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 40
Study 29308939 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping® (standard treatment plus application of Kinesio Taping® on the respiratory muscles)
Number of subjects: 62
Study 29308939 — intervention group
Group type: COMPARATOR
Intervention: Control (medication and standard physiotherapy treatment)
Number of subjects: 62
Study 27749236 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-TNF inhibitors
Number of subjects: 23
Study 26176044 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 45
Study 26176044 — intervention group
Group type: COMPARATOR
Intervention: Parenteral Nutrition (PN)
Number of subjects: 45
Study 23121563 — intervention group
Group type: EXPERIMENTAL
Intervention: Hb concentration of 7·3 g dL(‐1) (restrictive group)
Number of subjects: 50
Study 23121563 — intervention group
Group type: COMPARATOR
Intervention: Hb concentration of 8·9 g dL(‐1) (liberal group)
Number of subjects: 50
Study 20354452 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg/m MMC on day 1 and 125 mg/m irinotecan on days 2 and 9 (arm A)
Number of subjects: 76
Study 20354452 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/m MMC on days 1 and 8 and 125 mg/m irinotecan on days 2 and 9 (arm B)
Number of subjects: 76
Study 20354452 — intervention group
Group type: COMPARATOR
Intervention: Both arms (A and B)
Number of subjects: 76
Study 20354452 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm A
Number of subjects: 76
Study 20354452 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm B
Number of subjects: 76
Study 18606949 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive early-intervention program (OPUS)
Number of subjects: 547
Study 18606949 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 547
Study 16098423 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention for bifurcation lesions
Number of subjects: 11482
Study 16098423 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary intervention for nonbifurcation lesions
Number of subjects: 11482
Study 12546581 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 49
Study 12546581 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 49
Study 12546581 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of stay (LOS)
Number of subjects: 49
Study 10885880 — intervention group
Group type: EXPERIMENTAL
Intervention: Light mask illuminated at 1700 lux, with popliteal light pads extinguished
Number of subjects: 3
Study 10885880 — intervention group
Group type: EXPERIMENTAL
Intervention: Popliteal light pads illuminated (13,000 lux) and light mask at < 3 lux
Number of subjects: 3
Study 10885880 — intervention group
Group type: COMPARATOR
Intervention: No illumination from light pads applied to the popliteal fossae, with light mask maintained at < 3 lux
Number of subjects: 3
Study 8653869 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin and probucol
Number of subjects: 23
Study 8653869 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin and cholestyramine
Number of subjects: 23
Study 1918553 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal biofeedback (TBF) treatment with regular home practice (group 1)
Number of subjects: 69
Study 1918553 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal biofeedback (TBF) treatment without home practice (group 2)
Number of subjects: 69
Study 1918553 — intervention group
Group type: COMPARATOR
Intervention: Monitoring headaches (control group 3)
Number of subjects: 69
Study 6863881 — intervention group
Group type: EXPERIMENTAL
Intervention: Boots secretin
Number of subjects: 9
Study 6863881 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic secretin
Number of subjects: 9
Study 6863881 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (no specific intervention)
Number of subjects: 9
Study 6863881 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic CCK 8
Number of subjects: 9
Study 6863881 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline (used as diluent)
Number of subjects: 9
Study 29730456 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printing
Number of subjects: 20
Study 29730456 — intervention group
Group type: COMPARATOR
Intervention: Freehand technique
Number of subjects: 20
Study 29533028 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery + HIPEC
Number of subjects: 56
Study 29533028 — intervention group
Group type: COMPARATOR
Intervention: Cytoreductive surgery alone
Number of subjects: 56
Study 27011257 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit and nuts dietary pattern
Number of subjects: 118
Study 27011257 — intervention group
Group type: EXPERIMENTAL
Intervention: Seafood dietary pattern
Number of subjects: 118
Study 27011257 — intervention group
Group type: EXPERIMENTAL
Intervention: Yeast extract and seasonings dietary pattern
Number of subjects: 118
Study 26338739 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin 0.5 mg/kg/day
Number of subjects: 62
Study 26338739 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin 1.0 mg/kg/day
Number of subjects: 62
Study 26338739 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 62
Study 23110500 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylstilbestrol (DES) 1-3 mg daily with 75 mg aspirin
Number of subjects: 231
Study 20576472 — intervention group
Group type: COMPARATOR
Intervention: Intrauterine balloon only (group 1)
Number of subjects: 45
Study 20576472 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh amnion graft (group 2)
Number of subjects: 45
Study 20576472 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried amnion graft (group 3)
Number of subjects: 45
Study 20576472 — intervention group
Group type: EXPERIMENTAL
Intervention: Amnion graft (fresh vs dried)
Number of subjects: 45
Study 20576472 — intervention group
Group type: EXPERIMENTAL
Intervention: Amnion graft (overall)
Number of subjects: 45
Study 18837197 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical Twitch‐Obtaining Intramuscular Stimulation (eToims) using ET127 system, 3 Hz, 4 stimuli/site
Number of subjects: 92
Study 18837197 — intervention group
Group type: COMPARATOR
Intervention: Basic Group (BG) stimulation, 1 Hz, 1 stimulus/site
Number of subjects: 92
Study 16247790 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP with 80 mg/day of valsartan
Number of subjects: 40
Study 16247790 — intervention group
Group type: COMPARATOR
Intervention: CHOP without valsartan (control)
Number of subjects: 40
Study 12110072 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance exercise (LEX)
Number of subjects: 62
Study 12110072 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity resistance exercise (HEX)
Number of subjects: 62
Study 12110072 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study 10533775 — intervention group
Group type: COMPARATOR
Intervention: Oesophagectomy alone (group A)
Number of subjects: 74
Study 10533775 — intervention group
Group type: EXPERIMENTAL
Intervention: Neo-adjuvant chemoradiotherapy combined with oesophagectomy (group B)
Number of subjects: 74
Study 7488771 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrifugal pump (Biomedicus)
Number of subjects: 26
Study 7488771 — intervention group
Group type: COMPARATOR
Intervention: Roller pump (Stöckert)
Number of subjects: 26
Study 1690068 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoramin 20 mg bd
Number of subjects: 121
Study 1690068 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoramin 20 mg nocte
Number of subjects: 121
Study 1690068 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 7084142 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam solution 20 mg administered rectally
Number of subjects: 10
Study 7084142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31977610 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone data capture tool
Number of subjects: 100
Study 31977610 — intervention group
Group type: COMPARATOR
Intervention: Standard voice-dictated operative notes
Number of subjects: 100
Study 30789089 — intervention group
Group type: EXPERIMENTAL
Intervention: Unexpected objects associated with high reward value
Number of subjects: 537
Study 30789089 — intervention group
Group type: EXPERIMENTAL
Intervention: Unexpected objects associated with low reward value
Number of subjects: 537
Study 30789089 — intervention group
Group type: EXPERIMENTAL
Intervention: Unexpected objects associated with no reward value
Number of subjects: 537
Study 28657182 — intervention group
Group type: EXPERIMENTAL
Intervention: Blonanserin
Number of subjects: 0
Study 25592561 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified post-operative chemotherapy (SIOPWT2001)
Number of subjects: 238
Study 25592561 — intervention group
Group type: COMPARATOR
Intervention: Historical control chemotherapy (SIOP93-01)
Number of subjects: 238
Study 25592561 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified treatment in Stage I (SIOPWT2001)
Number of subjects: 238
Study 25592561 — intervention group
Group type: COMPARATOR
Intervention: Historical control treatment in Stage I (SIOP93-01)
Number of subjects: 238
Study 23803894 — intervention group
Group type: EXPERIMENTAL
Intervention: Disturbed sleep (2330-0730)
Number of subjects: 15
Study 23803894 — intervention group
Group type: COMPARATOR
Intervention: Nondisturbed sleep (control) (2330-0730)
Number of subjects: 15
Study 21717719 — intervention group
Group type: EXPERIMENTAL
Intervention: First measurement of sensitivity
Number of subjects: 29